Joint Preservation Innovations (JPI) is an orthopedic medical device company dedicated to advancing minimally invasive surgery through patented bone resection technologies. By enabling more patients to benefit from smaller incisions and faster recovery, we seek to redefine what’s possible in musculoskeletal care. By bringing together leading surgeons, engineers, and seasoned entrepreneurs, JPI focuses on conceptualizing, developing, and validating paradigm-shifting solutions for arthroscopic, robotic, and spinal procedures. Our diverse portfolio spans multiple projects at various stages of development and regulatory approval.

Introducing the Articulator™ Bone Resector
The world’s first FDA-approved arthroscopic articulating bone resection tool.

After more than 7 years of development and close collaboration with top orthopedic surgeons, the Articulator™ gives minimally invasive surgeons the ability to articulate rotary cutting tools inside the tight, constrained spaces of the human skeleton — something previously impossible with traditional straight-line instruments.

Awarded FDA Breakthrough Device Designation in 2023, the Articulator™ platform is designed to significantly reduce the surgical footprint of large-market procedures in arthroscopy, endoscopic spine surgery, and robotics — delivering greater precision, smaller incisions, and improved patient outcomes.

JPI is proud to be a member of mHUB, the nation’s leading hardtech innovation center.  We are actively building the future of joint preservation and minimally invasive orthopedics.

If you’re a surgeon, investor, engineer, or innovator passionate about transforming musculoskeletal surgery, we’d love to connect.

Joint Preservation Innovations

Org chart

Teams

Offices

Joint Preservation Innovations

Org chart

Teams

Offices

Related companies